United Therapeutics’ Inhaled Treprostinil May Get Second Quarter 2009 Action Date
This article was originally published in The Pink Sheet Daily
Executive Summary
NDA for the new formulation of Remodulin for pulmonary arterial hypertension was filed June 27.